Practitioner Channel PanTheryx already distributes bovine colostrum products through healthcare practitioner offices, suggesting a strong sales channel. The opportunity is to scale this channel by onboarding additional clinics and integrative medicine centers, and to develop private-label options for medical networks. Build education programs and targeted sampling to drive adoption among clinicians and patients.

GLP-1 Adjunct Relesium targets gut-related side effects of GLP-1 medications used for weight management, creating a natural entry point with endocrinology and obesity treatment programs. Opportunities include partnerships with clinics and care management programs, clinical research collaborations, and payer-ready value propositions around improved GI tolerance.

Probiotic Expansion The TruBiotics sugar-free probiotic gummies extension demonstrates consumer-friendly products that can cross-sell with colostrum lines. Potential sales strategy includes expanding direct-to-consumer efforts via the Shopify platform, building relationships with pediatricians and nutritionists, and bundling probiotic products with colostrum offerings for family health programs.

Global Alliances Past multi-year partnerships indicate appetite for international reach. Leverage existing or new alliances to enter APAC markets, explore co-development and distribution agreements, and tailor bovine colostrum products to regional regulatory and clinical study requirements to accelerate global sales.

Science Backed Growth Adding a menopause specialist to the Scientific Advisory Board and maintaining an R&D focus strengthens credibility for higher-value collaborations. Target hospitals, women's health clinics, early-life nutrition programs, and GI research centers for co-development, clinical studies, and premium product partnerships.